» Authors » L Brieva

L Brieva

Explore the profile of L Brieva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 477
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez O, Montalban X, Aguera E, Aladro Y, Alonso A, Arroyo R, et al.
Rev Neurol . 2024 Jul; 79(2):51-66. PMID: 38976584
The XVI Post-ECTRIMS meeting was held in Seville on 20 and 21 October 2023, where expert neurologists in multiple sclerosis (MS) summarised the main new developments presented at the ECTRIMS...
2.
Fernandez O, Montalban X, Aguera E, Aladro Y, Alonso A, Arroyo R, et al.
Rev Neurol . 2024 Jun; 79(1):21-29. PMID: 38934946
The XVI Post-ECTRIMS meeting took place in Seville on 20 and 21 October 2023. This meeting was attended by neurologists specialising in multiple sclerosis (MS) from Spain, who shared a...
3.
Fernandez O, Montalban X, Aguera E, Aladro Y, Alonso A, Arroyo R, et al.
Rev Neurol . 2023 Jul; 77(2):47-60. PMID: 37403243
Introduction: On 4 and 5 November 2022, Madrid hosted the 15th edition of the Post-ECTRIMS Meeting, where neurologists specialised in multiple sclerosis outlined the latest developments presented at the 2022...
4.
Fernandez O, Montalban X, Aguera E, Aladro Y, Alonso A, Arroyo R, et al.
Rev Neurol . 2023 Jun; 77(1):19-30. PMID: 37365721
Introduction: On 4 and 5 November 2022, Madrid hosted the 15th edition of the Post-ECTRIMS Meeting, where neurologists specialised in multiple sclerosis (MS) outlined the most relevant novelties presented at...
5.
Otero-Romero S, Rodriguez-Garcia J, Vilella A, Ara J, Brieva L, Calles C, et al.
Neurologia (Engl Ed) . 2020 Jun; 36(1):50-60. PMID: 32561334
Background: The recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the development of prevention and risk minimisation strategies. Vaccination is...
6.
Nogueras L, Gonzalo H, Jove M, Sol J, Gil-Sanchez A, Hervas J, et al.
Sci Rep . 2019 Aug; 9(1):11313. PMID: 31383928
Multiple sclerosis (MS) is a complex multifactorial neuropathology. Although its etiology remains unclear, it has been demonstrated that the immune system attacks myelin, leading to demyelination and axonal damage. The...
7.
Grau-Lopez L, Teniente-Serra A, Tintore M, Rovira A, Ramio-Torrenta L, Brieva L, et al.
Mult Scler . 2014 Aug; 21(5):646-50. PMID: 25145693
Unlabelled: Our aim was to investigate differences in immune mechanisms in multiple sclerosis (MS) relapse, after high-dose oral methylprednisolone (oMP) or intravenous methylprednisolone (ivMP). We measured serum cytokines (IL-2, IL-4,...
8.
Ramo-Tello C, Grau-Lopez L, Tintore M, Rovira A, Ramio I Torrenta L, Brieva L, et al.
Mult Scler . 2013 Oct; 20(6):717-25. PMID: 24144876
Background: Steroids improve multiple sclerosis (MS) relapses but therapeutic window and dose, frequency and administration route remain uncertain. Objective: The objective of this paper is to compare the clinical and...
9.
Purroy F, Begue R, Gil M, Quilez A, Sanahuja J, Brieva L, et al.
Eur J Neurol . 2010 May; 18(1):121-8. PMID: 20500525
Objective: diffusion-weighted magnetic resonance imaging (DWI) is a sensitive diagnostic tool for detecting acute ischaemic lesions in patients with transient ischaemic attacks (TIAs). The additional predictive value of DWI lesion...
10.
Bosma L, Kragt J, Brieva L, Khaleeli Z, Montalban X, Polman C, et al.
Mult Scler . 2010 May; 16(7):862-7. PMID: 20488826
For the Timed 25-Foot Walk (T25FW) and 9-Hole Peg Test (9HPT), components of the Multiple Sclerosis Functional Composite (MSFC), cut-off points of 20% change have previously been defined as meaningful...